Skip to main content
Figure 5 | Molecular Pain

Figure 5

From: Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia

Figure 5

Effects of STZ and DSP-4 on NET-immunoreactivity in L4-5 dorsal horn. Representative photomicrographs of NET-immunoreactivity in L4-5 dorsal horn in (A) vehicle + saline, (C) STZ + saline, (E) vehicle + DSP-4 and (G) STZ + DSP-4 rats at 6 weeks after STZ injection. Panels (B), (D), (F) and (H) are higher magnification of boxed area in (A), (C), (E) and (G), respectively. The scale bar in (A) is 50 μm and applies to (C), (E) and (G) and the scale bar in (B) is 12.5 μm and applies to (D), (F) and (H). (I) Quantification of NET-immunoreactivity in L4-5 dorsal horn at 6 weeks after STZ injection. Ratio of NET-immunoreactive pixels to the total pixel number in the dorsal horn gray matter (see Methods). Four to twelve dorsal horn samples were used for evaluating average ratio values in each rat. The mean ± SEM values of 4 rats for each experimental group are shown. *P < 0.05 (Mann–Whitney U-test) between vehicle (Veh) and STZ groups in saline-treated animals; #P < 0.05 (Mann–Whitney U-test) between saline-treated and DSP-4-treated groups in both STZ and Veh groups; NS, not significantly different.

Back to article page